Immunology and Microbiology
Peptoclostridium difficile
100%
Surface Property
55%
Infectious Agent
47%
Host Cell
41%
Enteropathogenic Escherichia Coli
39%
Bacteroides
35%
Biofilm
31%
Bacteroides fragilis
29%
Escherichia coli
26%
Virulence Factor
22%
Cell Adhesion
21%
Sporogenesis
19%
Cell Surface
17%
Cladistics
16%
Cell Wall
16%
Mobile Genetic Elements
14%
Antimicrobial Resistance
13%
Mouse
12%
Clostridium
12%
Vaccine Efficacy
11%
Immune Response
11%
Mouse Model
11%
Lineages
11%
Gastrointestinal Tract
11%
Transposon
11%
Antimicrobial Peptides
10%
Hamster Model
9%
Antibiotic Sensitivity
9%
Fibroblast
9%
Pilus
9%
Metabolite
9%
Syrian Hamster
9%
Vaccination Policy
9%
Symbiont
9%
Genomic Island
9%
Inverted Repeat
9%
Toxoid
9%
Epidermal Growth Factor
9%
Rifamycin
9%
Etest
9%
Receptor Binding
9%
Prevalence
9%
Clostridium perfringens
9%
Phylogenomics
9%
Sigma Factor
9%
Enzyme Immunoassay
9%
Tandem Repeat
9%
Bacilli
9%
Superoxide
9%
Microorganism
9%
Keyphrases
Bacteroides Sp
19%
Dihydropteroate Synthase
12%
Pilus-like Structure
9%
Ribotype 017
9%
SigL
9%
Polysaccharide Production
9%
RT027
9%
Groote Schuur Hospital
9%
Cell Wall Glycopolymers
9%
Glycopolymer
9%
Transfer Sequence
9%
Origin of Transfer
9%
Relaxosome
9%
Conjugation
9%
OriT
9%
EspH
9%
Mobilizable Transposon
9%
Transfer Factor
9%
Bacteroides Fragilis
9%
Integrase
9%
Bacteroides
9%
Synthetic Biologics
9%
Cationic Antimicrobial Peptides
9%
Mobile Genetic Elements
9%
Surface Layer Protein A
9%
Antimicrobial Resistance
9%
Cell Surface Properties
9%
Cwp84
9%
Sulfathiazole
9%
Antivirulence
9%
Historical Antecedents
9%
Conjugate Vaccine
9%
Pathogenicity Locus
9%
Avian Necrotic Enteritis
9%
Alpha-toxin
9%
Rifaximin
9%
Spore-forming Bacilli
9%
TcdR
9%
Clostridium Perfringens alpha-toxin
9%
Live Biotherapeutics
9%
Escherichia Coli
9%
Stone Culture
9%
Fis1
9%
Superoxide Reductase
9%
DNA Transfer
6%
TcdC
6%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Difficile Infection
34%
Peptoclostridium difficile
34%
Disease
29%
Infection
24%
Sulfathiazole
19%
Bacteroides
19%
Antibiotic Agent
13%
Dihydropteroate Synthase
12%
Antibiotic Resistance
10%
Anaerobic Bacterium
10%
Escherichia coli
10%
Inflammation
9%
Enteropathogenic Escherichia Coli
9%
Vaccination Policy
9%
Toxoid
9%
Antimicrobial Resistance
9%
Epidermal Growth Factor Receptor
9%
Anaerobe
9%
Microflora
9%
Non-Steroidal Anti-Inflammatory Drug
9%
Diarrhea
9%
Rifaximin
9%
Transfer Factor
9%
Polysaccharide
9%
Virulence Factor
9%
Antibiotic Associated Diarrhea
7%
Antibiotics
7%
Mouse
5%
Mouse Model
5%